Acute Care D-dimer
The D-dimer assay on the Stratus® CS Analyzer is an in vitro diagnostic test for the quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma. Elevated concentrations of D-dimer are indicative of the presence of fibrinolysis. As such, D-dimer measurements have been used as an aid in the diagnosis of DVT and PE disease.
When minutes matter, the Stratus® CS System delivers a fast, precise and accurate D-dimer result within 14 minutes. With a high negative predictive value (NPV), this D-dimer assay accurately diagnoses the VTE patient.
Delivering What Matters:
- Rapid turnaround time - in as little as 14 min. (with on-board centrifugation)
- Single and ready to use TestPaks
- No reconstitution
- No warming to room temperature
- Heparinized or citrated whole blood samples
- D-dimer and cardiac markers – one sample, one run, one instrument
- Substantial savings potential
- Single use TestPaks significantly reduce contamination and open stability issues, reducing reagent waste
- Electronic QC (System Check) satisfies daily routine QC requirements permitting liquid QC flexibility
- A negative quantitative D-dimer test in conjunction with a low pre-test probability score may reduce unnecessary diagnostic imaging procedures
Clinical Significance
When patients present with chest pain, it must quickly be determined if the cause is cardiac related, a pulmonary embolism (PE), or another condition. PE is an extremely common and highly lethal condition; the rapid diagnosis and treatment of a PE can result in a dramatic reduction of morbidity and mortality. Unfortunately, PE is often missed because it causes only vague and nonspecific symptoms.1
The Cardiovascular Disease: Evolution and Continuum document
For additional information on D-dimer visit our educational website at www.chestpainperspectives.com
1. Feied C, Handler JA. Pulmonary embolism. Available at : http://www.emedicine.com/EMERG/topic490.htm.
|
